EUVIMEDEUVIMED entdecken
Crossref

Oryzanol ameliorates MCD-induced metabolic dysfunction-associated steatohepatitis in mice via gut microbiota reprogramming and TLR4/NF-κB signaling suppression

Naqash Alam iD, Xinhua Ding, Yu Fu, Linying Jia, Sadiq Ali iD, Enqi Liu iD

American Journal of Physiology-Gastrointestinal and Liver Physiology · 2025

DOI: 10.1152/ajpgi.00190.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2025. Verfasst von Naqash Alam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Animal Center, School of Basic Medical Sciences, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Toll-Like Receptor 4, NF-kappa B, Phenylpropionates. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: 陕西省科学技术厅 | Natural Science Foundation of Shaanxi Province (Shaanxi Natural Science Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study demonstrates that oryzanol (ORY), a bioactive rice bran compound, alleviates metabolic dysfunction-associated steatohepatitis (MASH) in mice by reducing lipid accumulation and inflammation. ORY beneficial effects are associated to the modulation of gut microbiota, enhancing gut barrier integrity, and lowering endotoxemia and TLR4/NF-κB signaling pathway. These findings suggest ORY potential in MASH prevention and treatment, highlighting its influence on gut-liver axis dynamics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeToll-Like Receptor 4NF-kappa BPhenylpropionatesNon-alcoholic Fatty Liver DiseaseFatty LiverAnimalsMaleMice, Inbred C57BLSignal TransductionMiceLiverDisease Models, Animal

Stichwörter der Autor:innen

16S rDNANASHgut barriergut microbiomeoryzanol

Substanzen

Toll-Like Receptor 4NF-kappa BTlr4 protein, mousePhenylpropionatesgamma-oryzanol

Autor:innen und Institutionen

  • Laboratory of Animal Center, School of Basic Medical Sciences, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China.
  • Institute of Cardiovascular Sciences, School of Basic Medical Sciences, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China.

ORCID-Profile: Naqash Alam, Sadiq Ali, Enqi Liu

Förderung

  • 陕西省科学技术厅 | Natural Science Foundation of Shaanxi Province (Shaanxi Natural Science Foundation)

Zitieren

APA

Alam, N., Ding, X., Fu, Y., Jia, L., Ali, S., & Liu, E. (2025). Oryzanol ameliorates MCD-induced metabolic dysfunction-associated steatohepatitis in mice via gut microbiota reprogramming and TLR4/NF-κB signaling suppression. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00190.2024

Vancouver

Alam N, Ding X, Fu Y, Jia L, Ali S, Liu E. Oryzanol ameliorates MCD-induced metabolic dysfunction-associated steatohepatitis in mice via gut microbiota reprogramming and TLR4/NF-κB signaling suppression. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2025. doi:10.1152/ajpgi.00190.2024

BibTeX
@article{Alam2025,
  author = {Alam, Naqash and Ding, Xinhua and Fu, Yu and Jia, Linying and Ali, Sadiq and Liu, Enqi},
  title = {Oryzanol ameliorates MCD-induced metabolic dysfunction-associated steatohepatitis in mice via gut microbiota reprogramming and TLR4/NF-κB signaling suppression},
  journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
  year = {2025},
  doi = {10.1152/ajpgi.00190.2024}
}
Kostenlos starten →